SCHEMBL6600660

SCHEMBL6600660

Cc1ncn(Cc2ccc3ccccc3c2)c1Cn1cc(C(=O)N2CCN(C)CC2)c(-c2cccc3ccccc23)c1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FNTA P49354 10/20 0.60
FNTB P49356 10/20 0.60
PGGT1B P53609 3/20 0.60
CYP3A4 P08684 1/20 0.60
HTR2C P28335 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP2D6 P10635 1/20 0.38
CCR3 P51677 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600496 0.92 FNTA (0.51) FNTAFNTBPGGT1BCYP3A4HTR2C
SCHEMBL6602839 0.91 FNTA (0.50) FNTAFNTBPGGT1BCYP3A4HTR2C
SCHEMBL6599575 0.83 FNTA (0.67) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6600562 0.83 FNTA (0.49) FNTAFNTBPGGT1BCYP3A4HTR2C
SCHEMBL6599835 0.82 FNTA (0.49) FNTAFNTBPGGT1BCYP3A4HTR2C
SCHEMBL6606555 0.82 FNTA (0.65) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6601443 0.82 FNTA (0.65) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6599698 0.81 FNTA (0.75) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6607629 0.81 FNTA (0.75) FNTAFNTBPGGT1BCYP3A4KDM4E
SCHEMBL6608433 0.81 FNTA (0.64) FNTAFNTBPGGT1BCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 EP claimed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 US claimed
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 US disclosed
EP-1169320-A4 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2002-10-30 EP disclosed
EP-1169320-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG Chem Investment, Ltd. (KR) 2002-01-09 EP disclosed
WO-2000064891-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD. (KR) 2000-11-02 WO disclosed